Diagnosis and Prevalence of Cirrhotic Cardiomyopathy: A Systematic Review and Meta-analysis

Shahvaran, S.A. [Shahvaran, Seyed Alireza (Medicine), szerző] Semmelweis Egyetem; Menyhárt, O. [Menyhárt, Orsolya (Belgyógyászat), szerző] Belgyógyászati és Hematológiai Klinika (SE / AOK / K); Csedrik, L. [Csedrik, Lisa (Orvostudomány), szerző] Általános Orvostudományi Kar (SE); Patai, Á.V. ✉ [Patai, Árpád V (Belgyógyászat), szerző] Belgyógyászati és Hematológiai Klinika (SE / AOK / K)

Angol nyelvű Összefoglaló cikk (Folyóiratcikk) Tudományos
Megjelent: CURRENT PROBLEMS IN CARDIOLOGY 0146-2806 1535-6280 40 (10) Paper: 100821 , 10 p. 2021
  • SJR Scopus - Medicine (miscellaneous): D1
Azonosítók
The proposed diagnostic criteria for cirrhotic cardiomyopathy (CCM), defines it as documented echocardiographic findings of systolic or diastolic dysfunction (using conventional 2D echocardiogram), with or without electrophysiological abnormalities or elevated biomarkers in cirrhotic patients. In comparison to 2D echocardiogram, tissue Doppler imaging (TDI) has better sensitivity and specificity, when evaluating for cardiac dysfunction. This meta-analysis of 12 selected cohort studies attempted to estimate the pooled prevalence of CCM using either conventional echocardiography or TDI. Using the 2005 criteria, the pooled prevalence of CCM is 61% (P = 0.106). When TDI is used, the prevalence of CCM is at 45% (P = 0.088). Analyzing data of 615 cirrhotic patients, this study estimates the mean population-specific echocardiographic values of cirrhotic patients, including left ventricle ejection fraction (63.52%), deceleration time (229.04 ms), isovolumetric relaxation time (87.71 ms) and E/A ratio (1.04). In comparison to TDI, using standard 2D echocardiography leads to overdiagnosis of CCM. © 2021 The Author(s)
Hivatkozás stílusok: IEEEACMAPAChicagoHarvardCSLMásolásNyomtatás
2025-03-29 23:54